公开(公告)号：US20110258915A1

公开(公告)日：2011-10-27

申请号：US13124631

申请日：2009-10-19

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C10L1/188 ,  A01G1/00 ,  C07C29/88 ,  B01D35/02 ,  C12M1/12 ,  C07K1/14

CPC classification number: C12P7/649 ,  C12M21/02 ,  C12M23/04 ,  C12M33/14 ,  C12M43/02 ,  C12P7/18 ,  C12P7/20 ,  C12P7/6427 ,  C12P7/6463 ,  C12P7/6472 ,  C12P21/00 ,  Y02E50/13 ,  Y02P20/134

Abstract: Methods and apparatus for growing and sequentially processing algae to produce a variety of products including but not limited to biofuels, algal meal, oil, unsaturated fatty acids and recombinant proteins and peptides in a cost-effective and energy efficient manner. Also provided are methods of use for the products.

Abstract translation: 用于生长和依次加工藻类以以成本有效和节能的方式生产多种产品，包括但不限于生物燃料，藻粉，油，不饱和脂肪酸和重组蛋白质和肽的方法和装置。 还提供了用于产品的方法。

公开(公告)号：US20190032004A1

公开(公告)日：2019-01-31

申请号：US16118769

申请日：2018-08-31

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C12N1/20 ,  C12M1/00 ,  A61K35/74 ,  C12M1/12 ,  C12M3/00 ,  A61K9/00 ,  C12N1/04 ,  C12N7/00

Abstract: One embodiment provides a commensal gut production platform for ex vivo production of human gut commensal microbiota. Another embodiment provides devices, systems and methods for ex vivo culturing of gut microflora in a system that mimics the human gut environment. The culturing of the commensal microbiota in the disclosed systems produces gut microbiota having defined characteristics and properties that can be exploited to treat various conditions in a subject.

公开(公告)号：US20180030406A1

公开(公告)日：2018-02-01

申请号：US15656539

申请日：2017-07-21

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C12N1/20 ,  A61K9/00 ,  A61K35/74 ,  C12N1/04 ,  C12M1/34 ,  C12M1/00 ,  C12M3/00 ,  C12M1/12 ,  C12N7/00 ,  A61K35/00

CPC classification number: C12N1/20 ,  A61K9/0031 ,  A61K9/0053 ,  A61K35/74 ,  A61K2035/11 ,  C12M23/02 ,  C12M23/06 ,  C12M23/20 ,  C12M23/42 ,  C12M25/10 ,  C12M41/12 ,  C12M41/14 ,  C12M41/34 ,  C12N1/04 ,  C12N7/00 ,  C12N2795/00032 ,  C12N2795/00051 ,  C12R1/01 ,  C12R1/145 ,  C12R1/19 ,  C12R1/46 ,  G01N33/558

Abstract: One embodiment provides a commensal gut production platform for ex vivo production of human gut commensal microbiota. Another embodiment provides devices, systems and methods for ex vivo culturing of gut microflora in a system that mimics the human gut environment. The culturing of the commensal microbiota in the disclosed systems produces gut microbiota having defined characteristics and properties that can be exploited to treat various conditions in a subject.

公开(公告)号：US10246677B2

公开(公告)日：2019-04-02

申请号：US15893028

申请日：2018-02-09

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C12N1/20 ,  C12N1/00 ,  C12N1/12 ,  A61K9/00 ,  A61K35/74 ,  C12N7/00 ,  C12N1/04 ,  C12M3/00 ,  C12M1/34 ,  C12M1/00 ,  C12M1/12 ,  A61K35/00 ,  C12R1/46 ,  C12R1/19 ,  C12R1/01 ,  C12R1/145 ,  G01N33/558

Abstract: One embodiment provides a commensal gut production platform for ex vivo production of human gut commensal microbiota. Another embodiment provides devices, systems and methods for ex vivo culturing of gut microflora in a system that mimics the human gut environment. The culturing of the commensal microbiota in the disclosed systems produces gut microbiota having defined characteristics and properties that can be exploited to treat various conditions in a subject.

公开(公告)号：US20180030403A1

公开(公告)日：2018-02-01

申请号：US15221927

申请日：2016-07-28

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C12N1/20 ,  C12M1/00 ,  C12M1/34 ,  A61K9/00 ,  C12N1/04 ,  C12N7/00 ,  A61K35/74 ,  C12M1/12 ,  C12M3/00

CPC classification number: C12N1/20 ,  A61K9/0031 ,  A61K9/0053 ,  A61K35/74 ,  A61K2035/11 ,  C12M23/02 ,  C12M23/06 ,  C12M23/20 ,  C12M23/42 ,  C12M25/10 ,  C12M41/12 ,  C12M41/14 ,  C12M41/34 ,  C12N1/04 ,  C12N7/00 ,  C12N2795/00021 ,  C12N2795/00032 ,  C12N2795/00051 ,  C12R1/01 ,  C12R1/145 ,  C12R1/19 ,  C12R1/46 ,  G01N33/558 ,  Y02A50/463 ,  Y02A50/473 ,  Y02A50/475

Abstract: One embodiment provides a commensal gut production platform for ex vivo production of human gut commensal microbiota. Another embodiment provides devices, systems and methods for ex vivo culturing of gut microflora in a system that mimics the human gut environment. The culturing of the commensal microbiota in the disclosed systems produces gut microbiota having defined characteristics and properties that can be exploited to treat various conditions in a subject.

公开(公告)号：US10138460B2

公开(公告)日：2018-11-27

申请号：US15656539

申请日：2017-07-21

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C12N1/20 ,  C12N1/00 ,  C12N1/12 ,  A61K9/00 ,  A61K35/74 ,  C12N7/00 ,  C12N1/04 ,  C12M3/00 ,  C12M1/34 ,  C12M1/00 ,  C12M1/12 ,  A61K35/00

Abstract: One embodiment provides a commensal gut production platform for ex vivo production of human gut commensal microbiota. Another embodiment provides devices, systems and methods for ex vivo culturing of gut microflora in a system that mimics the human gut environment. The culturing of the commensal microbiota in the disclosed systems produces gut microbiota having defined characteristics and properties that can be exploited to treat various conditions in a subject.

公开(公告)号：US20180171284A1

公开(公告)日：2018-06-21

申请号：US15893028

申请日：2018-02-09

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C12N1/20 ,  C12M1/12 ,  A61K9/00 ,  A61K35/74 ,  C12N7/00 ,  C12N1/04 ,  C12M1/34 ,  C12M1/00 ,  C12M3/00 ,  A61K35/00

CPC classification number: C12N1/20 ,  A61K9/0031 ,  A61K9/0053 ,  A61K35/74 ,  A61K2035/11 ,  C12M23/02 ,  C12M23/06 ,  C12M23/20 ,  C12M23/42 ,  C12M25/10 ,  C12M41/12 ,  C12M41/14 ,  C12M41/34 ,  C12N1/04 ,  C12N7/00 ,  C12N2795/00032 ,  C12N2795/00051 ,  C12R1/01 ,  C12R1/145 ,  C12R1/19 ,  C12R1/46 ,  G01N33/558 ,  Y02A50/463 ,  Y02A50/473 ,  Y02A50/475

Abstract: One embodiment provides a commensal gut production platform for ex vivo production of human gut commensal microbiota. Another embodiment provides devices, systems and methods for ex vivo culturing of gut microflora in a system that mimics the human gut environment. The culturing of the commensal microbiota in the disclosed systems produces gut microbiota having defined characteristics and properties that can be exploited to treat various conditions in a subject.

公开(公告)号：US20180030405A1

公开(公告)日：2018-02-01

申请号：US15598488

申请日：2017-05-18

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C12N1/20 ,  C12M3/00 ,  C12M1/34 ,  C12M1/12 ,  C12M1/00

Abstract: One embodiment provides a commensal gut production platform for ex vivo production of human gut commensal microbiota. Another embodiment provides devices, systems and methods for ex vivo culturing of gut microflora in a system that mimics the human gut environment. The culturing of the commensal microbiota in the disclosed systems produces gut microbiota having defined characteristics and properties that can be exploited to treat various conditions in a subject.

公开(公告)号：US20120322106A1

公开(公告)日：2012-12-20

申请号：US13579641

申请日：2011-02-18

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: C12N9/42 ,  C10L1/182 ,  C07K14/00 ,  C12P7/64 ,  C12P7/06 ,  C12N15/74 ,  C10L1/188 ,  C12P21/00

CPC classification number: C12N9/2437 ,  C10G2300/1014 ,  C10L1/02 ,  C10L1/026 ,  C12N1/12 ,  C12P7/649 ,  Y02E50/13 ,  Y02E50/17 ,  Y02P30/20

Abstract: A method for producing hemicellulase and cellulase for use in processing cellulosic materials for biofuel production. The method involves transforming algal feedstock to express hemicellulase and cellulase and then collecting hemicellulase and cellulase that has been secreted into a culture medium by the algae. The method may further involve transforming the algal feedstock to express other recombinant products and/or processing the alga feedstock to produce biofuels.

Abstract translation: 一种生产半纤维素酶和纤维素酶的方法，用于加工用于生物燃料生产的纤维素材料。 该方法包括转化藻类原料以表达半纤维素酶和纤维素酶，然后收集通过藻类分泌到培养基中的半纤维素酶和纤维素酶。 该方法还可以包括转化藻类原料以表达其他重组产物和/或加工藻类原料以生产生物燃料。

公开(公告)号：US20220257753A1

公开(公告)日：2022-08-18

申请号：US17669191

申请日：2022-02-10

Applicant: Bobban Subhadra

Inventor： Bobban Subhadra

IPC: A61K39/39 ,  A61K39/00 ,  A61K39/12 ,  A61K39/02 ,  A61P37/04 ,  A61P31/16

Abstract: Cellulose nanoparticle formulations, containing cellulose nanocrystals or nanofibrils, for use as vaccine adjuvants and/or as antigen delivery systems, and the use of the adjuvant formulations in immunogenic and vaccine compositions with different antigens. Cellulose nanoparticle formulations demonstrate enhancements in humoral and cellular immunogenicity of vaccine antigens, particularly subunit vaccine antigens, when utilized alone or in combination with immunostimulatory agents. Further identification of physical and chemical properties of the cellulose nanoparticle formulations can be manipulated to enhance antigen efficiency and adjuvant tolerability in vivo. Relating to the use of the formulations in the treatment of diseases of humans and animals.